Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Geraldine Murden"'
Autor:
Matthew Winter, Rob Coleman, Jessica Kendall, Carlo Palmieri, Chris Twelves, Sacha Howell, Iain MacPherson, Caroline Wilson, Kash Purohit, Jacqui Gath, Christine Taylor, Richard Eastell, Geraldine Murden, Sarah R. Brown, Emma Rathbone, Janet Brown
Publikováno v:
Journal of Bone Oncology, Vol 35, Iss , Pp 100442- (2022)
Background: Approximately 70% of patients with metastatic breast cancer (MBC) develop bone metastases. Despite advances in systemic treatment options and the use of bone targeted agents in the management of bone metastases to reduce skeletal morbidit
Externí odkaz:
https://doaj.org/article/f4c9910e2ee343c2970db1a4f3955768
Autor:
Gerard M. Walls, Jamie B. Oughton, Anthony J. Chalmers, Sarah Brown, Fiona Collinson, Martin D. Forster, Kevin N. Franks, Alexandra Gilbert, Gerard G. Hanna, Nicola Hannaway, Stephen Harrow, Tom Haswell, Crispin T. Hiley, Samantha Hinsley, Matthew Krebs, Geraldine Murden, Rachel Phillip, Anderson J. Ryan, Ahmed Salem, David Sebag-Montefoire, Paul Shaw, Chris J. Twelves, Katrina Walker, Robin J. Young, Corinne Faivre-Finn, Alastair Greystoke
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 25, Iss , Pp 61-66 (2020)
Lung cancer is the leading cause of cancer mortality worldwide and most patients are unsuitable for ‘gold standard’ treatment, which is concurrent chemoradiotherapy. CONCORDE is a platform study seeking to establish the toxicity profiles of multi
Externí odkaz:
https://doaj.org/article/18ea8996e30244118c8f0fb5dfce7ad3
Autor:
Hannah L. Buckley, Fiona J. Collinson, Gemma Ainsworth, Heather Poad, Louise Flanagan, Eszter Katona, Helen C. Howard, Geraldine Murden, Rosamonde E. Banks, Joanne Brown, Galina Velikova, Tom Waddell, Kate Fife, Paul D. Nathan, James Larkin, Thomas Powles, Sarah R. Brown, Naveen S. Vasudev
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The combination of nivolumab, a programmed death-1 (PD-1) targeted monoclonal antibody, with the cytotoxic T-lymphocyte antigen-4 (CTLA-4) targeted antibody, ipilimumab, represents a new standard of care in the first-line setting
Externí odkaz:
https://doaj.org/article/62e16f703fca4bf2acf7b093a40e6f10
Autor:
P. Heudtlass, David Dodwell, J.F. Seligmann, S.R.D. Johnston, Galina Velikova, H. Passant, C. Price, Jamie B. Oughton, M. Rizwanullah, A. Wright-Hughes, Helen Marshall, Geraldine Murden, A. Pottinger
Publikováno v:
Clinical Oncology. 32:656-664
Aims Brain (central nervous system; CNS) metastases occur in 30–50% of patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC). A substantive evidence base for treatment is lacking, but activity with la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6eae50398ba13b27cd0ee7e9d5486a0
https://doi.org/10.1016/j.clon.2020.06.003
https://doi.org/10.1016/j.clon.2020.06.003
Autor:
Louise Flanagan, Paul Nathan, Sarah Brown, Rosamonde E. Banks, Geraldine Murden, Tom Waddell, Kate Fife, Thomas Powles, Hannah Buckley, James Larkin, Heather Poad, Fiona Collinson, Eszter Katona, Joanne Brown, Galina Velikova, Naveen S. Vasudev, Gemma Ainsworth, Helen Howard
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Background The combination of nivolumab, a programmed death-1 (PD-1) targeted monoclonal antibody, with the cytotoxic T-lymphocyte antigen-4 (CTLA-4) targeted antibody, ipilimumab, represents a new standard of care in the first-line setting for patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9547f1c60334675221047be28971ffb7
https://pubmed.ncbi.nlm.nih.gov/31727024
https://pubmed.ncbi.nlm.nih.gov/31727024
Autor:
David Sebag-Montefiore, Alison Smith, Sarah Brown, Geraldine Murden, Crispin T. Hiley, A. Hudson, Gerard Walls, Stephen Harrow, Gerard G Hanna, Sadie Reed, Corinne Faivre-Finn, Matthew G Krebs, Anderson J. Ryan, Paul Shaw, Caroline Dive, Samantha Hinsley, Alastair Greystoke, Tom Haswell, Anthony J. Chalmers, Nicola L. Hannaway, R. Young, Kevin Franks
Publikováno v:
Journal of Thoracic Oncology. 14:S641-S642
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f48bcb13bc1214f2711b1d2e25ed6b93
https://doi.org/10.1016/j.jtho.2019.08.1352
https://doi.org/10.1016/j.jtho.2019.08.1352